About ours
Create a pioneering enterprise specializing in macrophage therapy, dedicated to the development of cutting-edge treatments for cancer and autoimmune diseases.
Create a pioneering enterprise specializing in macrophage therapy, dedicated to the development of cutting-edge treatments for cancer and autoimmune diseases.
Create cost-effective cancer treatments accessible to the general public.
United Focus、Courage in Action、Continuous Innovation、Impact Beyond Ourselves.
Meritocracy in talent selection、Our culture thrives on diversity, and every voice is empowered to innovate freely、Collaborative growth and shared success、Timely recognition with meaningful rewards、Unity through equitable practices、Compassionate integrity.
RocRock Bio is a strategic high-tech biomedicine enterprise established by Dr. Yin Xiushan, a Chinese scientist returning from Europe, who leads a team of Ph.D.s from renowned institutions such as the Karolinska Institute in Sweden, the European Molecular Biology Laboratory, and the German National Center for Molecular Medicine. The company leverages over a decade of cutting-edge interdisciplinary research to develop innovative solutions in the field of life sciences.
To date, we have secured 3 invention patents and 18 utility patents, spanning a wide range of areas from core technologies to production processes and comprehensive system solutions.
As a high-tech enterprise dedicated to technological innovation and product development, we view our R&D capabilities as the cornerstone of our competitive edge.
Our team comprises leading scientists and experts who bring deep professional knowledge and extensive hands-on experience in cell therapy. Hailing from world-class universities and research institutions, they integrate interdisciplinary skills spanning cell biology, molecular biology, and clinical medicine.
Drag & Drop Website Builder